Abstract

Gene–diet interactions may play an important role in the inter individual diversity observed in on cardiovascular disease (CVD) risk factors. Therefore, in the current study, we examined the interaction of CETP TaqB1 polymorphism with dietary insulin index and load (DII and DIL), in altering on CVD risk factors among type 2 diabetes mellitus (T2DM). In this cross-sectional study, blood samples were collected from 220 type 2 diabetic patients (134 females and 86 male) with a mean age of 52.24 years in Tehran, Iran. DIL and DII were obtained via validated food-frequency questionnaire (FFQ). Taq1B polymorphism was genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Biochemical markers including total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), superoxide dismutase (SOD), C-reactive protein (CRP), total antioxidant capacity (TAC), pentraxin-3 (PTX3), isoprostaneF2α (PGF2α). interleukin 18 (IL18), leptin and ghrelin were measured by standard protocol. Patients with B1B1 genotype had lower lipid profiles include LDL/HDL (P < 0.001) and TG (P = 0.04) when they consumed diets higher on the DIL and DII index. Moreover, carriers of B2B2 genotype who were in the last tertile of DIL had higher antioxidant and inflammatory markers include SOD (P = 0.01), PGF2α (P = 0.04) and CRP (P = 0.02). Further, a significant interaction between CETP TaqB1 and DII was shown in terms of WC (P = 0.01), where the highest WC were observed in B2B2 genotype carriers following a DII score. However, the highest inflammatory and antioxidant markers include CRP (P = 0.04), TAC (P = 0.01), SOD (P = 0.02), and PGF2α (P = 0.02) were observed in B2B2 genotype carriers when they consumed diets higher on the DII index. Based on the current study, it could be proposed that CETP polymorphism may be associated with CVD risk factors in T2DM patients with high following insulin indices, including DII and DIL. It seems that CETP Taq1B polymorphism can invert the result produced by insulin. This conclusion illustrates that the CETP Taq1B B1 allele could counteract the CVD risk induced by high DII and DIL.

Highlights

  • Type 2 diabetes mellitus (T2DM) is a metabolic disorder that imposes an enormous burden on public health, which raise to 700 million by ­20451

  • There is a relationship between rs708272 and various cardiovascular disease (CVD) risk factors including type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, and low high-density lipoprotein (HDL), the evidence is controversial: other studies have indicated a lack of such ­associations[7,8,9]

  • In the current study, we examined the interaction of cholesteryl ester transfer protein (CETP) TaqB1 with dietary insulin index and load, in altering on cardiovascular risk factors including obesity indices (WC and body mass index (BMI)), lipid profiles (TG, HDL, low-density lipoprotein (LDL)/HDL), inflammatory markers (IL-18, C-reactive protein (CRP), and PGF2α), and antioxidant markers (TAC and superoxide dismutase (SOD))

Read more

Summary

Introduction

Type 2 diabetes mellitus (T2DM) is a metabolic disorder that imposes an enormous burden on public health, which raise to 700 million by ­20451. One of the most important of environmental factors is diet, which play a major role in development of T2DM and C­ VD10 It seems that foods can induce postprandial insulin secretion and affect the management of hyperlipidemia, CVD, obesity, and D­ M11. Some findings revealed that the CETP polymorphism interacts with dietary carbohydrate intake on metabolic factors, such as hypertension, dyslipidemia, obesity, insulin resistance (IR) and ­DM19. In this regard, several studies proposed a potential interaction between CETP SNP and dietary fat on plasma lipid and lipoprotein c­ oncentrations[20,21,22]. The number of researchers did not show that the TaqIB polymorphism in the CETP gene can affect cardio-metabolic responses to dietary i­ntakes[23,24,25]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call